Cleopatra Hospitals Group S.A.E. (EGX:CLHO)
Egypt · Delayed Price · Currency is EGP 12.08
-0.03 (-0.25%)
At close: Apr 2, 2026
EGX:CLHO Income Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 7,227 | 5,420 | 3,595 | 2,584 | 2,549 | |
Revenue Growth (YoY) | 33.34% | 50.76% | 39.13% | 1.36% | 28.13% |
Cost of Revenue | 4,369 | 3,407 | 2,387 | 1,719 | 1,619 |
Gross Profit | 2,858 | 2,013 | 1,209 | 865.27 | 930.67 |
Selling, General & Admin | 1,229 | 749.8 | 494.19 | 376.47 | 344.94 |
Other Operating Expenses | 29.72 | 55.63 | 10.46 | 14.51 | 11.96 |
Operating Expenses | 1,368 | 856.27 | 551.86 | 419.36 | 402.87 |
Operating Income | 1,490 | 1,157 | 656.76 | 445.91 | 527.79 |
Interest Expense | -224.7 | -122.05 | -69.55 | -35.72 | -34.44 |
Interest & Investment Income | 46.63 | 35.15 | 25.02 | 37.08 | 59.59 |
Earnings From Equity Investments | 10.07 | 4.71 | - | - | - |
Currency Exchange Gain (Loss) | -2.62 | 7.78 | 2.78 | 8.42 | -0.01 |
Other Non Operating Income (Expenses) | -2.44 | -0.01 | -3.29 | - | - |
EBT Excluding Unusual Items | 1,317 | 1,083 | 611.71 | 455.68 | 552.93 |
Merger & Restructuring Charges | -0.33 | -0.9 | -2.3 | -4.29 | -17.52 |
Gain (Loss) on Sale of Assets | 2.37 | 1.91 | -0.32 | 0.21 | -0.79 |
Asset Writedown | 0 | - | - | - | - |
Pretax Income | 1,319 | 1,084 | 609.09 | 451.6 | 534.62 |
Income Tax Expense | 351.23 | 266.65 | 135.53 | 93.37 | 123.95 |
Earnings From Continuing Operations | 967.87 | 817.01 | 473.56 | 358.23 | 410.67 |
Earnings From Discontinued Operations | - | - | -4.26 | -1.5 | - |
Net Income to Company | 967.87 | 817.01 | 469.3 | 356.73 | 410.67 |
Minority Interest in Earnings | -143.98 | -93.67 | -51.12 | -30.97 | -23.43 |
Net Income | 823.88 | 723.35 | 418.18 | 325.76 | 387.25 |
Preferred Dividends & Other Adjustments | 154.06 | 156.06 | 98.6 | 67.95 | 66.13 |
Net Income to Common | 669.82 | 567.29 | 319.58 | 257.81 | 321.12 |
Net Income Growth | 13.90% | 72.97% | 28.37% | -15.88% | 34.97% |
Shares Outstanding (Basic) | 1,442 | 1,442 | 1,442 | 1,515 | 1,599 |
Shares Outstanding (Diluted) | 1,444 | 1,444 | 1,444 | 1,517 | 1,599 |
Shares Change (YoY) | - | - | -4.82% | -5.11% | -0.08% |
EPS (Basic) | 0.46 | 0.39 | 0.22 | 0.17 | 0.20 |
EPS (Diluted) | 0.46 | 0.39 | 0.22 | 0.17 | 0.20 |
EPS Growth | 17.95% | 77.27% | 30.17% | -15.50% | 33.50% |
Free Cash Flow | -758.57 | -1,204 | -267.2 | 15.19 | 365.99 |
Free Cash Flow Per Share | -0.53 | -0.83 | -0.18 | 0.01 | 0.23 |
Gross Margin | 39.55% | 37.14% | 33.62% | 33.48% | 36.51% |
Operating Margin | 20.62% | 21.35% | 18.27% | 17.26% | 20.70% |
Profit Margin | 9.27% | 10.47% | 8.89% | 9.98% | 12.60% |
Free Cash Flow Margin | -10.50% | -22.21% | -7.43% | 0.59% | 14.36% |
EBITDA | 1,710 | 1,341 | 811.22 | 581.11 | 643.75 |
EBITDA Margin | 23.66% | 24.75% | 22.56% | 22.49% | 25.25% |
D&A For EBITDA | 219.7 | 184.26 | 154.46 | 135.19 | 115.95 |
EBIT | 1,490 | 1,157 | 656.76 | 445.91 | 527.79 |
EBIT Margin | 20.62% | 21.35% | 18.27% | 17.26% | 20.70% |
Effective Tax Rate | 26.63% | 24.61% | 22.25% | 20.67% | 23.18% |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.